RU93016671A - IMMUNODULATOR - Google Patents
IMMUNODULATORInfo
- Publication number
- RU93016671A RU93016671A RU93016671/14A RU93016671A RU93016671A RU 93016671 A RU93016671 A RU 93016671A RU 93016671/14 A RU93016671/14 A RU 93016671/14A RU 93016671 A RU93016671 A RU 93016671A RU 93016671 A RU93016671 A RU 93016671A
- Authority
- RU
- Russia
- Prior art keywords
- impaired
- diseases associated
- immunity
- lymphotoxic
- lymphotropic
- Prior art date
Links
- 201000010099 disease Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 230000036039 immunity Effects 0.000 claims 2
- 230000001771 impaired Effects 0.000 claims 2
- 210000001744 T-Lymphocytes Anatomy 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 229940079593 drugs Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 230000002519 immonomodulatory Effects 0.000 claims 1
- 239000002955 immunomodulating agent Substances 0.000 claims 1
- 230000002584 immunomodulator Effects 0.000 claims 1
- 229940121354 immunomodulators Drugs 0.000 claims 1
- 230000001917 lymphotoxic Effects 0.000 claims 1
- 230000003000 nontoxic Effects 0.000 claims 1
- 231100000252 nontoxic Toxicity 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 239000002994 raw material Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-O tris(2-hydroxyethyl)azanium Chemical compound OCC[NH+](CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-O 0.000 claims 1
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU93016671A RU2108100C1 (en) | 1993-03-31 | 1993-03-31 | Immunomodulating agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU93016671A RU2108100C1 (en) | 1993-03-31 | 1993-03-31 | Immunomodulating agent |
Publications (2)
Publication Number | Publication Date |
---|---|
RU93016671A true RU93016671A (en) | 1995-05-10 |
RU2108100C1 RU2108100C1 (en) | 1998-04-10 |
Family
ID=20139569
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU93016671A RU2108100C1 (en) | 1993-03-31 | 1993-03-31 | Immunomodulating agent |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2108100C1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007073231A1 (en) * | 2005-12-23 | 2007-06-28 | Victor Lvovoch Limonov | Agent for treating tumoral diseases, a method for the production thereof and a method for treating tumoral diseases |
RU2642778C2 (en) * | 2016-04-04 | 2018-01-26 | Федеральное государственное бюджетное учреждение науки Иркутский институт химии им. А.Е. Фаворского Сибирского отделения Российской академии наук | Method for obtaining of 1-r-indole-3-ylsulfanylacetates of (2-hydroxyethyl)ammonium |
-
1993
- 1993-03-31 RU RU93016671A patent/RU2108100C1/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO954996D0 (en) | Use of nona and decapeptides for the manufacture of a medicament for the treatment of AIDS | |
BG101118A (en) | Therapeutical compounds | |
ES2092890T3 (en) | APPLICATION OF RILUZOLE IN THE TREATMENT OF PARKINSON'S DISEASE AND PARKINSON'S SYNDROMES. | |
ES2058892T3 (en) | USE OF OMEPRAZOLE AS ANTIMICROBIAL AGENT. | |
LU90856I2 (en) | Uprima - apomorphine hydrochloride and its pharmaceutically acceptable derivatives | |
MX9305248A (en) | DIARILPIPERAZINOACETAMIDA COMPOUNDS. | |
NO922936D0 (en) | PREPARATION OF FATIC ACID MEDICINES | |
SE9201930D0 (en) | GASTRIC ANTIBACTERIAL TREATMENT | |
ES2177024T3 (en) | EMPLOYMENT OF THE FANQUINOMA FOR THE TREATMENT OF ALZHEIMER'S DISEASE. | |
MX9707642A (en) | Pharmaceutical agents for the treatment of alzheimer's disease. | |
RU93016671A (en) | IMMUNODULATOR | |
BR0116653A (en) | Medicinal product containing a polyamine as active substance | |
EE03514B1 (en) | A combination of compounds for the treatment of HIV infection or AIDS, its use and a pharmaceutical composition | |
AU2880595A (en) | Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses | |
EA199900963A1 (en) | MEDICAL FORMS OF SERTRALIN IN THE FORM OF A SOLUTION CONCLUDED IN GELATINIC CAPSULES | |
AU5061090A (en) | Aids therapy | |
ES2049711T1 (en) | USE OF BUCILAMINE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF CYSTINURIA. | |
KR960003718A (en) | Use of Ifenprodil and its Diastereomers for the Preparation of Medicines Useful for the Treatment of Peripheral and Central Neurodegenerative Diseases | |
HK1011527A1 (en) | Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases | |
DK0703781T3 (en) | Use of Efaroxan and its Derivatives for the Preparation of a Drug to Treat Parkinson's Disease | |
ES1034986Y (en) | APPARATUS FOR THE TREATMENT OF THE HUMAN BODY. | |
RU93030389A (en) | MEANS RESTORING THE FUNCTION OF THE MESH EYE | |
GB9209599D0 (en) | Novel therapy for the treatment of parkinsons disease | |
NO304011B1 (en) | Use of atipamezole in the manufacture of a medicament for the treatment of men's impotence | |
ATE90565T1 (en) | TREATMENT OF SHOCK WITH CYCLODEXTRIN AND ITS DERIVATIVES. |